Pharming Group N.V. PHAR

Updated: 18 Jun 2026

Euronext Amsterdam | Biotech | Rare diseases and precision medicine

No signal published yet

We already track Pharming Group N.V. and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Pharming Group N.V. free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
Euronext Amsterdam
Type
Biotech
Sector
Rare diseases and precision medicine
We're already tracking Pharming Group N.V. — here are the latest events we've registered

Recent News

  • In June 2026, the U.S. FDA accepted Pharming's resubmitted supplemental New Drug Application for Joenja (leniolisib) to treat children aged 4–11 with APDS, with a PDUFA action date set for October 24, 2026. The company also presented at the Jefferies Global Healthcare Conference and reaffirmed its full-year 2026 revenue guidance.

What Firelda Watch includes for Pharming Group N.V.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Pharming Group N.V. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Black Mammoth Metals Corp
BMM
NEUTRAL
Crustal Resources B
HOLD
Crustal Minerals
CRUST B
NEUTRAL
Bioarctic
BIOA B
BUY
Swedish Orphan Biovitrum AB (publ)
SOBI
HOLD

Biotech

More companies in this sector

Want to follow Pharming Group N.V.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Pharming Group N.V. free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Pharming Group N.V. PHAR
Pharming Group N.V. — follow and we'll monitor it
Follow Pharming Group N.V. free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.